New Tinnitus Treatment Study Gives Hope to Millions

LONDON, March 25, 2015 /PRNewswire/ --

The chance of an improved life for six million people in the UK living with tinnitus is offered by an extensive study published this week.

Tinnitus affects around 10% of the population in the UK and in its severe form can cause sleep loss, anxiety, depression and a significant reduction in their quality of life.

Now, a year-long study by independent research organisation CERES, shows that the innovative Acoustic CR® Neuromodulation treatment is effective in reducing tonal tinnitus symptoms such as severity and loudness and annoyance by nearly 40%.

Of the 200 patients treated in 23 ENT centres across Germany, 67% reported that their tinnitus had improved, and 50% said that their tinnitus no longer had a negative influence on their quality of life.

"Patients in this study had tinnitus for more than four years, and the majority had at least two other treatments before taking the Acoustic CR® Neuromodulation," said Chief Audiologist Mark Williams at the Tinnitus Clinic Ltd. in Harley Street, which is acknowledged as UK's leading private treatment centre for tinnitus.

"This peer-reviewed study shows without doubt, that in a clinical setting, Acoustic CR® Neuromodulation offers both progressive and sustainable therapeutic benefit to people affected by chronic tonal tinnitus."

Robert Stanley, a patient who has recently completed his Acoustic CR® Neuromodulation treatment at The Tinnitus Clinic, said, "I would say my tinnitus is 80% better than it was and I believe that the Acoustic Neuromodulation programme has significantly reduced my tinnitus both in frequency and volume. It has given me my quality of life back."

Editors' notes:

Full article is available at http://www.hindawi.com/journals/bmri/aip/569052/

Photos - available on request

Further details and information on tinnitus and treatments can be found on http://www.thetinnitusclinic.co.uk

Acoustic CR® Neuromodulation

The Tinnitus Clinic is the sole UK provider of the pioneering treatment, Acoustic CR® Neuromodulation which treats tonal tinnitus using the NTR T30 CR® Neurostimulator device.

Acoustic CR® Neuromodulation therapy is designed to desynchronise nerves in the hearing part of the brain, by using the brains natural plasticity. This desynchronisation reduces the strength of the links between nerve clusters, shifting a nerve population from a synchronised (pathological) state to a stable desynchronised (healthy and normal) state, where the nerve clusters will remain after treatment. The package includes device, medical earphones, carrying case, charger, fitting appointment and 5 further follow up recalibration appointments lasting at least 1 hour each. The treatment would usually take around 6 - 8 months.

CERES GmbH (Clinical Research Organization), Lörrach, Germany